Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dianhydrogalactitol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 42 for your search:
Start Over
Phase I-II Chemotherapy with Galactitol for Advanced Brain, Lung, Breast, Gastrointestinal and Genitourinary Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-705642
Phase I-II Chemotherapy with CTX, ADR, DAG, VP-16, PZD and TZT for Solid Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-750302
CAP-I (CTX/ADR/CACP) vs DAG/ADR/CACP for Squamous Cell Lung Cancer with VCR or VBL for Failures (Summary last modified 06/97)
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D77-020-265, MAYO-772251, NCCTG-772251
Phase II Early Trial of Dianhydrogalactitol plus BCNU for Advanced Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D78-020-108, MAYO-780301
Phase II Chemotherapy with Galactitol for Carcinoma, Sarcoma and Leukemia in Children
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor: NCI
Protocol IDs: POG-7604
Phase II Chemotherapy with Dianhydrogalactitol for Primary and Secondary Brain Tumors
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: BTRC-3
Phase II Chemotherapy with Galactitol for Treatment of Advanced Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7520
Phase II Chemotherapy with Single Agents Selected by Soft Agar Colony Sensitivity Studies for Advanced Renal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-805002, NCCTG-805002, NCI-W81-0587
Phase II Single-Agent Chemotherapy in Patients with Advanced Ovarian Carcinoma Using Agents Selected by Soft Agar Colony Sensitivity Studies
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-816101
Phase II Single-Agent Chemotherapy with DAG for Grade IV Malignant Central Nervous System Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: NCI-D79-035-116
Phase II Chemotherapy with Dianhydrogalactitol for Advanced Carcinoma of the Lung and for Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-0702
Phase II Master Protocol for Advanced, Recurrent Gynecologic Malignancies: Dianhydrogalactitol
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-26E
Phase II Dianhydrogalactitol as a Synchronizing Agent Prior to Chemotherapy with MTX/VCR in Patients with Refractory or Metastatic Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-045-430
Phase II Chemotherapy with DAG for Grade III/IV Astrocytoma Resistant to Radiotherapy and Nitrosoureas
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-006-645, YALE-HIC-2467
Phase II Chemotherapy with DAG/BCNU/PALA for Recurrent Primary Brain Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-817202, NCI-W81-0563
Phase II Pilot Study of Dianhydrogalactitol for Advanced Metastatic Malignancies
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: PCCC-PU-7744
Phase II L-PAM/DAG plus Total Body Irradiation for Neuroblastoma, with 6OH-Dopamine/Ascorbic Acid Treated Autologous Bone Marrow for Reconstitution
Phase: Phase II
Type: Treatment
Status: Closed
Age: 45 and under
Sponsor: NCI
Protocol IDs: MSKCC-8178, NCI-T83-0869W, T83-0869
Phase II Pilot Chemotherapy with CACP plus Radiotherapy plus VP-16/L-PAM/DAG plus Autologous Bone Marrow Therapy for Refractory Metastatic Rhabdomyosarcoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: MSKCC-8410, NCI-T84-0359D, T84-0359
Phase II Pilot Study of DAG/CACP Chemotherapy for Advanced Squamous Cancer of the Uterine Cervix
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PC-879
Phase II Chemotherapy with CTX, VP-16, Galactitol and Hormonal Therapy with Megestrol for Advanced Renal Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1874, MAYO-706025
Phase II Trials of 13 Additional Chemotherapeutic Agents, Alone or Combined for non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2575-II
A Master Protocol for Phase II Chemotherapy for Advanced Pancreatic Carcinoma --- HMM, DAG, b-TGdR, ICRF-159
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-9376A
Phase II Single-Agent Chemotherapy with VP-16 vs Dianhydrogalactitol for Disseminated Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-705612
Phase II Chemotherapy with CTX, ADR, VP-16, VCR, cis-Platinum, PZD, TZT and DAG for Solid Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-750305
Phase II Chemotherapy with Galactitol Versus Combination of VP-16 and ADR for Unresectable Adenocarcinoma of the Lung
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-752101
Start Over